Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer

NCT00452985 · clinicaltrials.gov ↗

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Neoplasms

Interventions

DRUG: Docetaxel
DRUG: Carboplatin

Sponsor

Sanofi